Xiangrong Dai
Direktor/Vorstandsmitglied bei ZHAOKE OPHTHALMOLOGY LIMITED
Vermögen: 190 530 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Xiangrong Dai
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 | |
Anhui Agricultural University
5
| College/University | Other Consumer Services | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Xiangrong Dai
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| The Chinese University of Hong Kong | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Graduate Degree | |
Hong Kong Institute of Certified Public Accountants
 Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
CVie Therapeutics Co., Ltd.
 CVie Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology CVie Therapeutics Co., Ltd. manufactures drugs to treat hypertension and acute heart failure. The private company is based in Hong Kong, Hong Kong. | Pharmaceuticals: Major | Director/Board Member President | |
| Stanford University | College/University | Graduate Degree Graduate Degree | |
Guangzhou Zhaokang Hospital Co., Ltd.
 Guangzhou Zhaokang Hospital Co., Ltd. Hospital/Nursing ManagementHealth Services Part of Guangzhou Haofeng Operation Management Co. Ltd., Guangzhou Zhaokang Hospital Co., Ltd. is a company that operates hospitals. Guangzhou Zhaokang Hospital Co., Ltd. is based in Guangzhou, China. Guangzhou Zhaokang Hospital Co. was acquired by Guangzhou Haofeng Operation Management Co. Ltd. from Lee's Pharmaceutical Holdings Ltd. on September 22, 2022 for $28.36 million. The Chinese company was founded in 2015. | Hospital/Nursing Management | Chairman Director/Board Member | |
| The Hong Kong University of Science & Technology | College/University | Corporate Officer/Principal Undergraduate Degree | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Standard Chartered Bank (Singapore) Ltd.
 Standard Chartered Bank (Singapore) Ltd. Regional BanksFinance Standard Chartered Bank (Singapore) Ltd. provides banking and finacial services. Its services include online banking, straight2bank, mobile banking app, online trading and online unit trusts. The company was founded in 1859 and is headquartered in Singapore. | Regional Banks | Corporate Officer/Principal | |
| Bailixing Xiamen Equity Investment Co. Ltd. | Director/Board Member | ||
| Acrostar Pharmaservices Corp. | Director/Board Member | ||
| Acrostar Site Management Co. Ltd. | Director/Board Member | ||
Novotech Holdings Pty Ltd.
 Novotech Holdings Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Novotech Health Holdings engages in the development of contract research organization platform. The company was founded on October 12, 2020 and is headquartered in Australia. | Miscellaneous Commercial Services | Director/Board Member | |
| Novotech Aus Holdco Pty Ltd. | Director/Board Member | ||
Novotech Health Holdings Ltd.
 Novotech Health Holdings Ltd. BiotechnologyHealth Technology Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore. | Biotechnology | Director/Board Member | |
| DINGDANG HEALTH TECHNOLOGY GROUP LTD. | Internet Software/Services | Director/Board Member | |
| Ppc Holding Co. | Director/Board Member | ||
ACEA Therapeutics, Inc.
 ACEA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acea Therapeutics, Inc. provides health care services. It specializes in lung cancer, lupus and lymphoma treatments. The company was founded by Xiao Xu and Xiaobo Wang is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
V3 Brands Asia Ltd.
 V3 Brands Asia Ltd. Household/Personal CareConsumer Non-Durables V3 Brands Asia Ltd. operates as an investment holding company. It engages in the sale and marketing of lifestyle and wellness products in Singapore. The company operates through three reportable segments: Retail, Distribution and Corporate. The Retail segment operates lifestyle and wellness products. The Distribution segment engages in the distribution of lifestyle and wellness products. The Corporate segment is involved in the group level corporate services, investment properties, treasury functions, group financing and investments. V3 Brands Asia was founded by Chye Hock Sim in 1979 and is headquartered in Singapore. | Household/Personal Care | Director/Board Member | |
| Aplus Pharmaceutical Consulting Shanghai Co. Ltd. | Director/Board Member | ||
V3 Group Ltd.
 V3 Group Ltd. Specialty StoresRetail Trade V3 Group Ltd. is an investment holding company, which engages in the development of lifestyle and wellness products. It operates its business through the following segments: Lifestyle, Wellness, and Corporate. The Lifestyle segment retails lifestyle and tea products. The Wellness segment sells nutraceutical products and supplements. The Corporate segment comprises of group-level corporate services; investment properties; treasury functions; and group financing and investments. The company was founded by Chye Hock Sim on March 9, 2016 and is headquartered in Singapore. | Specialty Stores | Director/Board Member | |
| GLOBAL BRANDS GROUP HOLDING LIMITED | Apparel/Footwear | Corporate Officer/Principal | |
Goldman Sachs (Asia) LLC
 Goldman Sachs (Asia) LLC Investment Banks/BrokersFinance Goldman Sachs (Asia) LLC (GS-Asia) is the Hong Kong-based brokerage subsidiary of Goldman Sachs Holdings (Hong Kong) Ltd., ultimately owned by The Goldman Sachs Group, Inc. (NYSE: GS), a multinational investment bank and financial services company headquartered in New York City. Founded in 1984, GS-Asia provides market insight, risk management and execution services to institutional clients which includes asset managers, hedge funds, banks and brokerages, pensions, endowments and foundations, corporations, and governments. | Investment Banks/Brokers | Director of Finance/CFO | |
| Fudan University | College/University | Undergraduate Degree | |
| University of Virginia | College/University | Graduate Degree | |
| Jiasheng Shanghai Pharmaceutical Consulting Co. Ltd. | Director/Board Member | ||
Biosuntek Laboratory Co. Ltd.
 Biosuntek Laboratory Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Biosuntek Laboratory Co. Ltd. is a South Korean company that specializes in testing and analysis services. The private company is based in Seongnam, South Korea. | Miscellaneous Commercial Services | Director/Board Member | |
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd.
 Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. engages in the development of eye treatment. It also focuses on licensing potential ophthalmology products and introduce it as accessible and affordable therapies to patients suffering from ophthalmic diseases in China. The company was founded on July 24, 2017 and is headquartered in Hong Kong. | Pharmaceuticals: Major | Director/Board Member | |
| SINO ENERGY INTERNATIONAL HOLDINGS GROUP LIMITED | Specialty Stores | Comptroller/Controller/Auditor | |
| The Hong Kong Polytechnic University | College/University | Undergraduate Degree | |
| UNI-BIO SCIENCE GROUP LIMITED | Medical Specialties | Comptroller/Controller/Auditor | |
| KPMG (Shenzhen) | Corporate Officer/Principal | ||
| SHANGHAI DASHENG AGRICULTURE FINANCE TECHNOLOGY CO., LTD. | Chemicals: Agricultural | Director/Board Member | |
TPG Capital Asia Inc
 TPG Capital Asia Inc Investment ManagersFinance TPG Capital Asia Inc (TPG Asia) is a private equity subsidiary of TPG Capital Advisors LLC founded in 1992 by Richard Charles Blum, Jim Coulter, Rohit Kumar Pansalkar and David Bonderma. The firm is headquartered in Beijing, China. | Investment Managers | Private Equity Analyst | |
Novotech (Australia) Pty Ltd.
 Novotech (Australia) Pty Ltd. BiotechnologyHealth Technology Novotech (Australia) Pty Ltd. operates as a contract research organization. It provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services and central lab services. The firm offers patient recruitment and site selection, clinical operations and project management, medical and regulatory consulting, biometrics and data management solutions. The company was founded by Alek Safarian in 1996 and is headquartered in Sydney, Australia. | Biotechnology | Director/Board Member | |
| Hao Capital Co. Ltd. | Investment Managers | Corporate Officer/Principal | |
TPG Capital-China Ltd.
 TPG Capital-China Ltd. Financial ConglomeratesFinance Part of TPG, Inc., TPG Capital-China Ltd. provides investment services. The company is based in Beijing, China. | Financial Conglomerates | Corporate Officer/Principal | |
| Ppc China Clinical Research Corp. Ltd. | Director/Board Member | ||
Hangzhou Kangji Medical Instrument Co., Ltd.
 Hangzhou Kangji Medical Instrument Co., Ltd. Medical DistributorsDistribution Services Hangzhou Kangji Medical Instrument Co., Ltd. manufactures and distributes medical equipment and related accessories. Its business includes reusable and disposable instruments for laparoscopy, gynecology, urology, gastroenterology, and ENT specialties. The company was founded on August 24, 2004 and is headquartered in Hangzhou, China. | Medical Distributors | Director/Board Member | |
| SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
| Zhejiang Choisun Tea Development Co. Ltd. | Director/Board Member | ||
| KANGJI MEDICAL HOLDINGS LIMITED | Medical Specialties | Director/Board Member | |
| Shanghai Deyu Deqi Enterprise Management Consulting Co. Ltd. | Director/Board Member | ||
| Opc Co. Holdings Cayman Islands Ltd. | Director/Board Member | ||
| Opc Intermediate Holding Co. Cayman Islands Ltd. | Director/Board Member | ||
| Ppc Kk Japan Ltd. | Director/Board Member |
Statistik
International
| China | 20 |
| Hong Kong | 11 |
| Vereinigte Staaten | 7 |
| Cayman Islands | 5 |
| Singapur | 4 |
Sektoral
| Health Technology | 10 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 5 |
| Consumer Non-Durables | 3 |
Operativ
| Director/Board Member | 122 |
| Corporate Officer/Principal | 54 |
| Independent Dir/Board Member | 40 |
| Chairman | 16 |
| Undergraduate Degree | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Zuie Chin Huang | 41 |
| Hin Wing Wong | 36 |
| Li Cai | 31 |
| Yuk Lam Lo | 24 |
| Fui Kiang Liew | 15 |
| Lai Fan Tam | 12 |
| Yu Chen | 11 |
| Xin Yan Feng | 10 |
| Mauro Bove | 8 |
| Xiao Yi Li | 7 |
| Lit-Fui Lau | 7 |
| Suk Yan Yau | 6 |
| Hui Liu | 5 |
| Albert Tsai | 4 |
| Jiang Feng | 3 |
- Börse
- Insiders
- Xiangrong Dai
- Unternehmensverbindungen
